Authors: Andrew Ciupek, PhD, Associate Director, Clinical Research; Jennifer C. King, PhD, Chief Scientific Officer; Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program Doctors and scientists from around the world who are passionate about lung cancer convened last month [...]
Small cell lung cancer (SCLC) can be a highly aggressive form of lung cancer and can be difficult to treat. It is the rarest of the major lung cancer types and represents just 15% of all diagnoses. Unfortunately, few [...]
Author: Jennifer C. King, PhD, Chief Scientific Officer People diagnosed with small cell lung cancer (SCLC) have historically had limited treatment options—but researchers are working to change that. At the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, [...]
GO2 for Lung Cancer team pictured: Joelle Fathi, DNP, RN, ARNP, FAAN; Daniel Saez, MSc; Jennifer C. King, PhD By Jennifer C. King, PhD, Chief Scientific Officer and Daniel Saez, MSc, Manager, LungMATCH Navigation Program The [...]
Author: Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program, GO2 for Lung Cancer People with lung cancer receiving treatment may encounter acquired drug resistance—a reduction in treatment effectiveness over time. Tagrisso (osimertinib) is currently a frontline treatment for people [...]
Authors: Amy Kampschroeder MA, OTR/L, CHES, Manager, Patient Outreach and Special Initiatives and Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program In 2021, one of GO2 for Lung Cancer’s priorities continued to be bringing lung cancer education and empowerment to patients to help [...]
When you hear the doctor say the words “small cell lung cancer,” life suddenly changes. You may feel overwhelmed and grieved, lost or angry, or you may feel nothing at all. It is okay to move through all kinds [...]
Author: Jennifer C. King, PhD, Chief Scientific Officer, GO2 for Lung Cancer The World Conference on Lung Cancer features research on all types of thoracic cancers—and small cell lung cancer is no exception. There were many talks on new [...]
Don’t miss our deep dive on topics presented at IASLC's 2021 World Conference on Lung Cancer, including presentations from our very own GO2 for Lung Cancer Science and Research Team. Subscribe to our Magnifying LeNS newsletter and look out [...]
By Rashmi Acharya, MS, Coordinator, Science & Research, GO2 for Lung Cancer Unlocking the Biology of SCLC Patients with small cell lung cancer (SCLC) receive one-size-fits-all treatment because of limited knowledge about the biology of the disease. There are [...]